Amrize Ltd (AMRZ) Stock Forecast
AMRZ analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 3.75 / 5 from 20 analysts
- Price target
- $47.20 average of analyst targets
- Upside to target
- +24.8% from the latest close
- Next earnings
- October 28, 2026 EPS estimate $0.98
- 52-week range
- $36.09 – $65.86
AMRZ analyst ratings
20 analystsNumber of analysts at each rating.
AMRZ price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
AMRZ earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.00 | $0.88 | $1.06 | $0.98 | +2.4% | 8 |
| Current fiscal year (2026) | $2.42 | $2.12 | $2.79 | $2.14 | +13.1% | 17 |
| Next fiscal year (2027) | $2.71 | $2.15 | $3.16 | $2.42 | +11.8% | 17 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
AMRZ revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $3.83B | $3.54B | $3.98B | +4.3% | 13 |
| Current fiscal year (2026) | $12.51B | $12.17B | $12.69B | +5.9% | 23 |
| Next fiscal year (2027) | $13.06B | $11.83B | $13.65B | +4.4% | 23 |
AMRZ EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
AMRZ revenue: reported and forecast
AMRZ EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.16 | $1.05 | $1.06 | $1.03 | $1.00 | −13.7% | 0 up · 6 down |
| Current fiscal year (2026) | $2.68 | $2.53 | $2.49 | $2.45 | $2.42 | −9.9% | 3 up · 11 down |
| Next fiscal year (2027) | $3.11 | $2.99 | $2.86 | $2.76 | $2.71 | −12.9% | 0 up · 14 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
AMRZ earnings surprises
Reported EPS vs the consensus estimate for the last 6 quarters; AMRZ beat in 2 of 6.
What analysts expect from AMRZ
20 analysts cover Amrize; their consensus rating is buy (3.75 on a 1–5 scale, where 5 is a strong buy). The average price target is $47.20, 24.8% above the latest close of $37.82. Analysts expect earnings of $2.42 per share for 2026, +13.1% from a year earlier. For 2027 the average estimate is $2.71 per share on revenue of $13.1 billion. Amrize beat the EPS estimate in 2 of the last 6 quarters.
Related: AMRZ income statement, AMRZ key metrics, AMRZ chart. See the AMRZ stock overview for the latest quote and news.
AMRZ forecast FAQ
What is Amrize's price target?
The average analyst price target for Amrize is $47.20, 24.8% above the latest close of $37.82.
Is Amrize a buy, hold or sell?
Of 20 analysts covering Amrize, 7 rate it a strong buy, 3 a buy, 8 a hold, 2 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Amrize's EPS forecast?
Analysts forecast $2.42 per share for 2026 (range $2.12 to $2.79); for 2027 the estimate is $2.71.
What is Amrize's revenue forecast?
The average revenue estimate for 2026 is $12.5 billion, growth of 5.9%; for 2027 it is $13.1 billion.
When does Amrize report earnings?
Amrize is expected to report results for the quarter ending September 30, 2026 on October 28, 2026 after the market closes; the EPS estimate is $0.98.
Does Amrize usually beat earnings estimates?
Amrize reported EPS at or above the analyst estimate in 2 of the last 6 quarters.